Syndromes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Syndromes stocks.

Syndromes Stocks Recent News

Date Stock Title
Jul 3 ALXO Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 REGN Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2 REGN Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2 ALXO Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
Jul 2 REGN Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Jul 1 REGN Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Jul 1 ALXO Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
Jul 1 ALXO PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
Jul 1 OVID Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Jul 1 NSPR InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
Jun 28 ALMS Alumis, in trading debut, falls 22% from IPO price
Jun 28 REGN What's Going On With Regeneron Pharmaceuticals Stock On Friday?
Jun 28 REGN Regeneron lymphoma antibody drug endorsed for conditional approval in EU
Jun 28 ALXO Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Jun 28 REGN Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
Jun 28 ALMS Alumis prices IPO at $16 per share
Jun 28 ALMS Alumis Announces Pricing of Initial Public Offering
Syndromes

A syndrome is a set of medical signs and symptoms that are correlated with each other and, often, with a particular disease or disorder. The word derives from the Greek σύνδρομον, meaning "concurrence". In some instances, a syndrome is so closely linked with a pathogenesis or cause that the words syndrome, disease, and disorder end up being used interchangeably for them. This is especially true of inherited syndromes. For example, Down syndrome, Wolf–Hirschhorn syndrome, and Andersen syndrome are disorders with known pathogeneses, so each is more than just a set of signs and symptoms, despite the syndrome nomenclature. In other instances, a syndrome is not specific to only one disease. For example, toxic shock syndrome can be caused by various toxins; premotor syndrome can be caused by various brain lesions; and premenstrual syndrome is not a disease but simply a set of symptoms.
If an underlying genetic cause is suspected but not known, a condition may be referred to as a genetic association (often just "association" in context). By definition, an association indicates that the collection of signs and symptoms occurs in combination more frequently than would be likely by chance alone.Syndromes are often named after the physician or group of physicians that discovered them or initially described the full clinical picture. Such eponymous syndrome names are examples of medical eponyms. Recently, there has been a shift towards naming conditions descriptively (by symptoms or underlying cause) rather than eponymously, but the eponymous syndrome names often persist in common usage.

Browse All Tags